| Standard International Trade Classification (SITC) - level 4 - Sub-group |
5429 |
Medicaments, n.e.s. |
| Combined nomenclature 8 digits |
30046000 |
Medicaments containing any of the following antimalarial active principles: artemisinin "INN" for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine "INN"; artelinic acid or its salts; artenimol "INN"; artemotil "INN"; artemether "INN"; artesunate "INN"; chloroquine "INN"; dihydroartemisinin "INN"; lumefantrine "INN"; mefloquine "INN"; piperaquine "INN"; pyrimethamine "INN" or sulfadoxine "INN", put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives) |
| Combined nomenclature 8 digits |
30049000 |
Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or steroids used as hormones, alkaloids, provitamins, vitamins, their derivatives, antimalarial active principles and blinded clinical trial kits) |
| Combined nomenclature 8 digits |
30069300 |
Placebos and blinded or double-blinded clinical trial kits for a recognised clinical trial, put up in measured doses |
Statistical metainformation system
